BRIEF-Mayne Pharma sees H1 FY 2014 total rev $68 mln to $71 mln

Thu, 06 Feb - 8:07am

Feb 6 (Reuters) - Mayne Pharma Group Ltd MYX.AX :

* Says expects H1 FY 2014 total revenue of between $68.0 million - $71.0 million

* Says expects H1 FY 2014 reported npat of between $8.2 million - $8.4 million

* Source text for Eikon News Search ID:nASX4hDSqJ

((For more news, please click here MYX.AX ))

((Bangalore Newsroom; +91 80 6749 1130))

URN: 
urn:newsml:reuters.com:20140205:nWNBS00B4P:4
Topics: 
LEN RTRS PHAG AU PHAR CMPNY PHMR HECA DRU BLR ASIA

Contact Us

Due to the security nature of our business, personal meetings are only by pre-arranged appointment.
Phone at any time on

1300 987 995

info@ausmint.com